Variations in the quality of care of patients with acute myocardial infarction among Swiss university hospitals

International Journal for Quality in Health Care

Volumn 17, Issue 3, 2005, Pages 229-234

  Luthi, Jean Christophe ^a,b,c   McClellan, William M ^c,d   Flanders, W Dana ^c   Pitts, Stephen R ^c   Burnand, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Department of Health Observatory ^*  (Switzerland)

^c EMORY UNIVERSITY   (United States)

^d Georgia Medical Care Foundation   (United States)

Author keywords

Acute myocardial infarction; Clinical performance measurements; Quality indicators; Quality of health care; Variations

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEART MUSCLE REPERFUSION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING CESSATION; SWITZERLAND; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, PUBLIC; HOSPITALS, UNIVERSITY; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; SWITZERLAND; THROMBOLYTIC THERAPY;

EID: 21044451302     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/mzi024     Document Type: Article

References (27)

1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity in Europe. Eur Heart J 1997; 18: 1231-1248.
2. The GUSTO-investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
3. ISIS-3: a randomised comparison of streptokinase vs fissue plasminagen activator vs anistreplase and aspirin and heparin, versus aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 1992; 339: 753-770.
4. Krumholz HM, Radford NIJ, Wang Y, Chen J, Marciniak TA. Early β-blocker therapy for acute myocardial infarction in elderly patients. Am Intern Med 1999; 131: 648-654.
5. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327: 669-677.
6. Ryan TJ, Antman EM, Brooks NH et al. 1999 update: ACC/AHA Guidelines for the Management for Patients with Acute Myocardial Infarction: Executive Summary and Recommendations. A report of the American College of Cardiology/American Heart Association Taskforce for Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-1030.
7. Jencks SF, Wilensky GR. The health care quality improvement initiative: A new approach to quality assurance in Medicare. JAMA 1992; 268: 900-903.
8. Marciniak TA, Ellerbeck EF, Radford MJ et al. Improving the quality of care for Medicare patients with acute myocardial infarction. Results from the Cooperative Cardiovascular Project. JAMA 1998; 279: 1351-1357.
9. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA 2003; 289: 305-312.
10. Wennberg JE, Gittelsohn A. Small area variations in health care delivery. Science 1973; 182: 1102-1108.
11. Wennberg JE, Freeman JL, Culp WP. Are hospital services rationed in New Haven and over-utilized in Boston? Lancet 1987; 1: 1185-1189.
12. Selby JV, Fireman BH, Lundstrom RJ et al. Variations among hospitals in coronary angiography practices and outcomes in myocardial infarctions in a large health maintenance organization. N Engl J Med 1996; 335: 1888-1896.
13. O'Connor GT, Quinton HB, Traven ND, Ramunno LD, Dodds TA, Marciniak TA, et al. Geographic variation in the treatment of acute myocardial infarction. The Cooperative Cardiovascular Project. JAMA 1999; 281: 627-633.
14. MacLeod MCM, Finlayson AR, Pell JP, Findlay AN. Geographic, demographic and socio-economic variations in the investigation and management of coronary heart diseases in Scotland. Heart 1999; 81: 252-256.
15. Grandjour A, Kleinschmitt F, Lauterbach KW; the INTERCARE International Investigators. European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001). Eur Heart J 2002; 23: 858-868.
16. EUROASPIRE I and II Study Group. Clinical reality of coronary Prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001; 357: 995-1001.
17. Bourquin MG, Wietlisbach V, Rickenbach M, Perret F, Paccaud F. Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993: do they reflect the advances in scientific evidence from clinical trials? J Clin Epidemiol 1998; 51: 723-732.
18. Sarasin FP, Maschiangelo ML, Schaller ND, Heliot C, Mischeler S, Gaspoz JM. Successful implementation of guidelines for encouraging the use of β-blockers in patients for acute myocardial infarction. Am J Med 1999; 106: 499-505.
19. Urban P, Bernstein MS, Costanza MC, Simon R, Frey R, Erne P for the AMIS Investigators. An Internet-based registry of acute myocardial infarction in Switzerland (in German). Kardiovask Med 2000; 3: 430-440.
20. Naegeli B, Bertel O, Urban P et al. Der akute Myokardial Infarkt in der Schweiz: Resultate aus dem PINICS-Herzinfarkt-Register (in Gernman). Schweiz Med Wochensch 1998; 128: 729-736.
21. ESC/ACCC Committee for the redefinition of myocardial infarction. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-1513.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
23. Spertus JA, Radford MJ, Every NR; Ellerbeck Ef, Peterson ED, Krumholz HM. Challenges and opportunities in quantifying quality of care for acute myocardial infarction. Summary from the Acute Myocardial Infarction Working Group of the American Heart Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Diseases and Stroke. J Am Coll Cardiol 2003; 41: 1653-1663.
24. Burwen DR, Galusha DH, Lewis JM et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999. The Medicare Healthcare Quality Improvement Program. Arch Intern Med 2003; 163: 1430-1439.
25. Blumenthal D. The variation phenomenon in 1994. N Eng J Med 1994; 331: 1017-1018.
26. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Eng J Med 1989; 321: 1168-1173.
27. Chassin MR, Kosecoff J, Park RE et al. Does inappropriate use explain geographic variations in the use of health services? JAMA 1987; 258: 2533-2537.